Park National Corp’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,099
Closed -$243K 318
2018
Q3
$243K Buy
2,099
+6
+0.3% +$677 0.01% 294
2018
Q2
$264K Sell
2,093
-94
-4% -$11.4K 0.02% 281
2018
Q1
$237K Buy
2,187
+20
+0.9% +$2.21K 0.01% 307
2017
Q4
$237K Buy
2,167
+46
+2% +$4.59K 0.01% 315
2017
Q3
$209K Buy
+2,121
New +$206K 0.01% 325
2017
Q1
Sell
-1,707
Closed -$205K 348
2016
Q4
$205K Buy
+1,707
New +$189K 0.01% 313

Other funds holding CLB

Park National Corp's CLB Position: Q4 2018 in Review

Park National Corp sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 2,099 shares — an estimated $243K sold.

Park National Corp first reported a position in CLB in Q4 2016 and held it in 6 quarters. The position peaked at $264K in Q2 2018. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

  • Park National Corp reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
  • Park National Corp sold 2,099 Core Laboratories shares in Q4 2018, an estimated $243K.
  • Park National Corp first reported a position in Core Laboratories in Q4 2016 and held it in 6 quarters.
  • Park National Corp's Core Laboratories position peaked at $264K in Q2 2018.
  • 320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Park National Corp's 13F filing for Q4 2018, filed 2 Jan 2019.